Sohonos Capsule
Product Images NDC 15054-0100

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sohonos (NDC 15054-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sohonos 01)

Chemical structure of palovarotene, representing the molecular composition and bonds of the active ingredient in SOHONOS capsules.*

FDA Label Image

Principal Display Panel (1 mg Capsule Blister Pack Carton)

Packaging label for SOHONOS (palovarotene) capsules, 1 mg strength, oral dosage form. The box contains 14 capsules and includes warnings about birth defects and pregnancy. The labeler is Ipsen Biopharmaceuticals, Inc. Instructions for opening the prescription pack are depicted. The label displays the NDC 15054-0010-1 and pharmacist dispensing instructions.*

FDA Label Image

Principal Display Panel (1.5 mg Capsule Blister Pack Carton)

Box packaging label for SOHONOS capsules containing 1.5 mg palovarotene per capsule. The box includes warnings about birth defects and pregnancy, dosing instructions referencing prescribing information, and usage instructions for opening the package. It is labeled for oral use, contains 14 capsules, and is distributed by Ipsen Biopharmaceuticals, Inc.*

FDA Label Image

Principal Display Panel (2.5 mg Capsule Blister Pack Carton)

Packaging label for SOHONOS (palovarotene) capsules, 2.5 mg per capsule, by Ipsen Biopharmaceuticals, Inc. The label indicates oral use with 14 capsules per package and prominently features a warning that the drug causes birth defects and should not be used during pregnancy. The label also includes the NDC number 15054-0025-1, guidance for pharmacists to dispense in original carton with Medication Guide, and instructions on how to open the pack. The product is prescription only.*

FDA Label Image

Principal Display Panel (5 mg Capsule Blister Pack Carton)

This is the packaging label for SOHONOS (palovarotene) capsules, 5 mg per capsule, manufactured by Ipsen Biopharmaceuticals, Inc. The label indicates oral use with 14 capsules contained. It includes warnings about birth defects and pregnancy, instructions to dispense prescription packs intact, and directions for opening the package. The design features a purple and white color scheme with the brand logo and a barcode.*

FDA Label Image

Principal Display Panel (10 mg Capsule Blister Pack Carton)

Packaging label for SOHONOS (palovarotene) capsules, 10 mg per capsule, oral use. The label indicates the product contains 14 capsules and includes warnings about birth defects and pregnancy. The labeler is Ipsen Biopharmaceuticals, Inc. The NDC code 15054-0100-1 is visible. Instructions to dispense the prescription packs intact and how to open are included, along with the Ipsen logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.